Merit wins three-year supply deal with Novation:
This article was originally published in Clinica
Utah-based Merit Medical Systems has won a supply contract with Novation, an Irving, Texas supply company for US healthcare organisations VHA and University HealthSystem Consortium. The three-year agreement covers Merit's line of cardiology products, including diagnostic catheters, diagnostic guide wires, fluid management kits and components, inflation devices and angioplasty accessories and takes effect immediately and runs through July 31 2007. The deal also extends to health care organizations that purchase supplies through HealthCare Purchasing Partners International, a company that markets Novation purchasing agreements to non-members of VHA and UHC.
You may also be interested in...
UK start-up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country. See what Iceni’s CEO Rob Field said about it here.
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.